NanoString Skip Navigation

NanoString Technologies

1.888.358.6266

Site Navigation

  1. Technology
    1. Technology Overview
    2. Applications
    3. Publications
  2. Products
    1. Products Overview
    2. nCounter Instrumentation
    3. nCounter Assays
    4. nCounter Workflow
    5. Ordering Information
    6. Contact Sales
  3. Support
    1. Support Overview
    2. FAQs
    3. Support Literature
    4. nCounter Software
    5. Contact Support
  4. Community
    1. Community Overview
    2. Core & Service Lab Listings
    3. Upcoming Events
    4. Mail List
    5. Purchasing Tools
  5. Corporate
    1. Corporate Overview
    2. Management Team
    3. Media Center
    4. Locations
    5. Contact Us
    6. Careers
    7. Legal

Site Tools


The nCounter Analysis System uses a novel digital technology that is based on direct multiplexed measrements of gene expression and offers high levels of sensitivity and precision.

Press Releases

  • 2/3/2010 •

    William D. Young Joins NanoString Technologies as Executive Chairman of the Board

  • 11/18/2009 •

    NanoString Technologies Announces Research Collaboration with Broad Institute to Advance Understanding of Molecular Networks

  • 10/22/2009 •

    NanoString Technologies announced that the National Cancer Institute (NCI) has adopted its nCounter™ Analysis System at two of its core labs.

View all press releases

Upcoming Events

3/23–28/2010 ACMG
Albuquerque, NM
4/17–21/2010 AACR
Washington, DC
View all upcoming events

What's New

  • 1/6/2010 •

    NanoString launches the NanoString Reporter, a community newsletter about the nCounter Analysis System and its applications.

  • 12/1/2009 •

    New nCounter Virtual Gene Sets available for angiogenesis, apoptosis, breast cancer, cell cycle and stem cell expression analysis.

  • 12/16/2009 •

    Unlock your FFPE samples – new Technical Note demonstrates performance of the nCounter assay using RNA from FFPE samples and crude FFPE extracts.

Subscribe to this RSS Feed